The prevalence of obesity, hypertension, and type 2 diabetes mellitus - in other words, the metabolic syndrome - is increasing in the United States. In this setting, it is important to understand the effects of antihypertensives on parameters of the metabolic syndrome in addition to glucose metabolism. Here the authors review pertinent clinical studies.
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Internal Medicine